These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 567958)

  • 21. An automated method for the evaluation of jumping activity in mice. Effects of clonidine on morphine withdrawal.
    Alguacil LF; Alamo C; Iglesias V; Cuenca E
    Methods Find Exp Clin Pharmacol; 1989 Nov; 11(11):677-81. PubMed ID: 2622297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Activity of naloxone and naltrexone on the development of the morphine withdrawal syndrome].
    Piccinelli D; de Feo G; Mazzanti G
    Boll Soc Ital Biol Sper; 1986 Oct; 62(10):1221-8. PubMed ID: 3828120
    [No Abstract]   [Full Text] [Related]  

  • 23. Dipeptides delay the onset of morphine withdrawal in the mouse.
    Kovács GL; Szontágh L; Baláspiri L; Telegdy G
    Acta Physiol Hung; 1984; 63(1):83-4. PubMed ID: 6540034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of precipitated abstinence in methadone-dependent rats by delta 9-THC.
    Hine B; Torrelio M; Gershon S
    Psychopharmacol Commun; 1975; 1(3):275-83. PubMed ID: 1241452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amelioration of withdrawal symptoms in morphine addicted albino rats.
    Raman G; Ahmed M
    Indian J Exp Biol; 1977 Mar; 15(3):238-9. PubMed ID: 199541
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
    Hodgson SR; Hofford RS; Norris CJ; Eitan S
    Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enkephalinase inhibitors attenuate naloxone-precipitated withdrawal syndrome.
    Dzoljic MR
    NIDA Res Monogr; 1986; 75():575-8. PubMed ID: 3123978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice.
    Kreeger JS; Larson AA
    J Pharmacol Exp Ther; 1996 Nov; 279(2):662-7. PubMed ID: 8930169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonidine and naloxone-induced opiate withdrawal: a comparison between clonidine and morphine in man.
    Fantozzi R; Luciani G; Masini E; Blandina P; Mannaioni P
    Subst Alcohol Actions Misuse; 1980; 1(4):369-73. PubMed ID: 7302789
    [No Abstract]   [Full Text] [Related]  

  • 30. Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats.
    Iwamoto ET; Ho IK; Way EL
    J Pharmacol Exp Ther; 1973 Dec; 187(3):588-67. PubMed ID: 4797745
    [No Abstract]   [Full Text] [Related]  

  • 31. The actions of narcotic antagonists in morphine-dependent rhesus monkeys.
    Villarreal JE; Karbowski MG
    Adv Biochem Psychopharmacol; 1973; 8(0):273-89. PubMed ID: 4212386
    [No Abstract]   [Full Text] [Related]  

  • 32. Phosphodiesterase 4 inhibitors, rolipram and diazepam block the adaptive changes observed during morphine withdrawal in the heart.
    González-Cuello A; Sánchez L; Hernández J; Teresa Castells M; Victoria Milanés M; Laorden ML
    Eur J Pharmacol; 2007 Sep; 570(1-3):1-9. PubMed ID: 17601555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in ribonuclease in the central nervous system of mice during morphine dependence development, withdrawal and naloxone administration.
    Mohanakumar KP; Sood PP
    Clin Physiol Biochem; 1986; 4(2):159-63. PubMed ID: 2421960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitors of nitric oxide synthase and the opioid withdrawal syndrome.
    London ED; Kimes AS; Vaupel DB
    NIDA Res Monogr; 1995; 147():170-81. PubMed ID: 8742786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of reserpine on the morphine abstinence syndrome in mice (author's transl)].
    Kruszewska A; Langwiński R
    Ann Univ Mariae Curie Sklodowska Med; 1979; 34():133-9. PubMed ID: 318053
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats.
    Cox B; Ary M; Lomax P
    J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome.
    Mori T; Ito S; Matsubayashi K; Sawaguchi T
    Behav Pharmacol; 2007 Dec; 18(8):725-9. PubMed ID: 17989510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of morphine dependence by a lipopolysaccharide from Pantoea agglomerans.
    Okutomi T; Nishizawa T; Inagawa H; Soma G; Minami M; Satoh M; Mizuno D
    Eur Cytokine Netw; 1992; 3(4):417-20. PubMed ID: 1421014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of selective monoamine oxidase inhibitor drugs on morphine tolerance and physical dependence in mice.
    Garzon J; Fuentes JA; Del Rio J
    Neuropharmacology; 1979 Jun; 18(6):531-6. PubMed ID: 573375
    [No Abstract]   [Full Text] [Related]  

  • 40. Interferon modifies morphine withdrawal phenomena in rodents.
    Dafny N
    Neuropharmacology; 1983 May; 22(5):647-51. PubMed ID: 6192350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.